Loading...
Concentra Group Holdings Parent, Inc.
CON•NYSE
Healthcare
Medical - Equipment & Services
$21.45
$-0.34(-1.56%)
Concentra Group Holdings Parent, Inc. (CON) Financial Performance & Statements
Review Concentra Group Holdings Parent, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
3.38%
↑ 3.38%
Operating Income Growth
6.05%
↑ 6.05%
Net Income Growth
-7.45%
↓ 7.45%
Operating Cash Flow Growth
17.23%
↑ 17.23%
Operating Margin
16.01%
↑ 16.01%
Gross Margin
27.06%
↑ 27.06%
Net Profit Margin
8.09%
↑ 8.09%
ROE
34.18%
↑ 34.18%
ROIC
12.85%
↑ 12.85%
Concentra Group Holdings Parent, Inc. (CON) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Concentra Group Holdings Parent, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $465.04M | $489.64M | $477.92M | $467.60M |
| Cost of Revenue | $344.85M | $351.10M | $357.14M | $355.48M |
| Gross Profit | $120.19M | $138.53M | $120.77M | $112.12M |
| Gross Profit Ratio | $0.26 | $0.28 | $0.25 | $0.24 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $45.49M | $37.09M | $36.83M | $36.91M |
| Operating Expenses | $61.10M | $37.09M | $36.83M | $36.91M |
| Total Costs & Expenses | $405.95M | $403.40M | $393.97M | $392.38M |
| Interest Income | $0.00 | $0.00 | $205000.00 | $0.00 |
| Interest Expense | $26.44M | $24.06M | $9.32M | $10.08M |
| Depreciation & Amortization | $15.61M | $15.21M | $17.87M | $18.48M |
| EBITDA | $74.70M | $101.45M | $98.34M | $93.70M |
| EBITDA Ratio | $0.16 | $0.21 | $0.21 | $0.20 |
| Operating Income | $59.09M | $86.23M | $83.94M | $75.21M |
| Operating Income Ratio | $0.13 | $0.18 | $0.18 | $0.16 |
| Other Income/Expenses (Net) | -$26.44M | -$24.06M | -$12.79M | -$9.80M |
| Income Before Tax | $32.65M | $62.17M | $71.16M | $65.42M |
| Income Before Tax Ratio | $0.07 | $0.13 | $0.15 | $0.14 |
| Income Tax Expense | $9.85M | $16.41M | $18.10M | $15.14M |
| Net Income | $21.51M | $44.34M | $51.74M | $48.96M |
| Net Income Ratio | $0.05 | $0.09 | $0.11 | $0.10 |
| EPS | $0.17 | $0.35 | $0.41 | $0.39 |
| Diluted EPS | $0.17 | $0.35 | $0.41 | $0.39 |
| Weighted Avg Shares Outstanding | $127.64M | $127.34M | $126.59M | $126.59M |
| Weighted Avg Shares Outstanding (Diluted) | $127.64M | $127.34M | $126.59M | $126.59M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan